Rasmus Hogreffe, MSc.Med., MBA is considered as a Virtual Clinical Trials expert. His main goal is to improve treatment for patients by...
Experienced drug development professional with a demonstrated history of working across multiple business areas within the research industry
Is your organization working on establishing a scalable DCT strategy for 2021 and beyond?
As an industry leader and pioneer in decentralized trials, Medable has developed a robust readiness framework that we use when assessing protocol-fit readiness for optimised DCT design with our clients.
Join Rasmus Hogreffe and Andrew Mackinnon, as they uncover what it takes for organizations to be “ready” for the future of DCT.
Attendees will walk away with an understanding of the key areas of DCT evaluation, the different types of frameworks they can employ, an understanding of their organization’s own readiness, and how best to create a path forward for 2021 and beyond.